Panadol Cold

Quick links to important sections

Panadol Cold

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Panadol Cold

Property Description
Active ingredients Acetaminophen, Pseudoephedrine
Form Oral tablet or caplet
Pharmacological class Analgesic and Decongestant Combination
Common use Multi-symptom cold and flu relief
Origin Synthetic chemical substances

Panadol Cold is a synthetic combination medicine formulated as a fixed-dose oral product containing two distinct active ingredients: Acetaminophen and Pseudoephedrine. It is classified as an Upper Respiratory Combination drug, designed specifically to provide simultaneous multi-symptom relief from the generalized and localized discomforts associated with the common cold and flu symptoms. Acetaminophen is recognized as an analgesic and antipyretic agent, while Pseudoephedrine functions as a nasal decongestant.

The core of its composition involves the pairing of these two substances, placing the medicine within two major pharmacological classes. The effectiveness of Acetaminophen for reducing pain and fever in adults and children is clinically recognized and supported by systematic reviews. This action confirms that the medicine helps to ease general discomfort and reduce elevated body temperature. Similarly, Pseudoephedrine is an ingredient pharmacologically confirmed for its ability to reduce nasal blood flow, which decreases swelling and fluid buildup in the nasal passages. This characteristic provides targeted relief for the uncomfortable sensation of a stuffy nose or sinus congestion.

This medicine is generally supplied as an oral tablet or a film-coated caplet. The general purpose of this combination product is to offer coordinated comfort: managing systemic symptoms like fever and body aches while concurrently addressing local upper respiratory symptoms like nasal congestion, simplifying the approach to treating discomfort when both types of symptoms are present.

Regulatory References

  1. Pseudoephedrine: MedlinePlus Drug Information

What side effects are possible with Panadol Cold?

Possible Side Effects and Safety Information

The official safety profile of this medicine, which combines Acetaminophen and Pseudoephedrine, is structured around the documented risks of its active ingredients as classified by regulatory authorities.

Serious Adverse Reactions and Key Safety Risks

The most significant safety consideration is the risk of severe liver damage, including hepatic failure, associated with the Acetaminophen component, particularly when exceeding the recommended dosage. The Pseudoephedrine component is linked to rare but serious acute systemic vasoconstrictive events. These documented serious adverse reactions include Acute Coronary Syndrome (ACS), Posterior Reversible Encephalopathy Syndrome (PRES), and Severe Cutaneous Adverse Reactions (SCARs) like Stevens-Johnson Syndrome (SJS).

System-Organ Classifications and Frequency

Adverse reactions are classified according to the affected system. Reactions in the Nervous System and Psychiatric Disorders categories are often cited in regulatory documents. These include insomnia, nervousness, and headache, which are often classified as common effects of the sympathomimetic component. Less commonly reported effects include those affecting the Cardiac, Vascular, and Gastrointestinal systems.

Population-Specific Safety Notes

Specific caution is advised for certain patient populations as documented in official labeling. This includes individuals with severe hepatic or renal impairment. Furthermore, older adults and patients with pre-existing conditions like hypertension or certain heart diseases are noted to be at an increased risk of adverse reactions due to the properties of Pseudoephedrine.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of this combination medicine is defined by dual, distinct toxicity risks from its active components, Acetaminophen and Pseudoephedrine. Immediate medical attention is required in all cases of suspected overdose.

Documented Overdose Manifestations

Early signs are often nonspecific, including nausea, vomiting, loss of appetite, abdominal pain, and excessive sweating. However, the overdose may progress to severe systemic effects. Acetaminophen toxicity can lead to severe liver damage (hepatotoxicity) and acute liver failure. Clinical signs of liver injury, such as jaundice, may be delayed and are life-threatening.

Overdose due to the Pseudoephedrine component involves CNS and cardiovascular stimulation, presenting as fast or uneven heart rate (dysrhythmias), confusion, tremor, or seizures. Life-threatening outcomes include severe hypertension, myocardial infarction, and severe cerebral events, such as Reversible Cerebral Vasoconstriction Syndrome (RCVS).

Mandatory Emergency Actions

Seek immediate medical attention or contact a Poison Control Center right away, even if no symptoms are present. Quick medical attention is critical due to the time-sensitive nature of the overdose. The specific antidote, N-acetylcysteine, is documented for the Acetaminophen component. If severe symptoms occur, such as collapse, seizure, or sudden severe headache, emergency services must be contacted immediately. Management involves symptomatic and supportive treatment, including hospital monitoring for potential liver injury.

Therapeutic Uses of Panadol Cold

What Panadol Cold Treats: Main Uses and Benefits

Panadol Cold is applied across domains where additional symptomatic support is needed for acute illness. This medication is commonly used to help manage symptoms associated with acute episodes of cold and flu, including those related to physical discomfort, systemic imbalance, and heightened physiological activity.

This product is relevant for managing conditions characterized by periods of heightened symptoms and is widely used when supportive relief is needed during these acute episodes. The supportive relief is relevant for easing discomfort related to systemic imbalance (fever), physical discomfort (aches/pains), and heightened physiological activity (nasal congestion).

This symptomatic assistance helps patients cope more steadily with difficult episodes. Its application is relevant when supportive symptom management is appropriate.

“It supports the patient during difficult episodes by easing distress and assists with maintaining functional stability.”

Quick Fact: Symptomatic support for Systemic Discomfort and Nasal Strain

Regulatory References

  1. NIH DailyMed label

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Panadol Cold — Official Regulatory Information


Eligibility Scope

Populations for whom use is allowed (as stated in label):

  • Adults and adolescents 12 years of age and older.

Populations for whom use is not recommended (if applicable):

  • Children under 12 years of age.
  • Individuals who are pregnant.

Populations for whom use is contraindicated:

  • Patients with documented hypersensitivity to any ingredient.
  • Patients with severe hypertension or severe coronary artery disease.
  • Patients with severe hepatic impairment or phaeochromocytoma.
  • Patients currently taking or having recently discontinued (within 14 days) Monoamine Oxidase Inhibitors (MAOIs).
  • Individuals who are breastfeeding (lactating).

Age-Related Eligibility Rules

  • Use is not established or is explicitly discouraged for children under 12 years of age.
  • Older adults should use with caution due to the potential for increased sensitivity to the decongestant component.

Condition-Specific Eligibility Rules

  • Contraindicated: Severe hepatic impairment.
  • Use with Caution/Conditional: Mild-to-moderate renal or hepatic impairment, diabetes mellitus, hyperthyroidism, narrow-angle glaucoma, and controlled hypertension.

Connection to the Overall Eligibility Profile

Regulatory documents strictly define eligibility based on minimum age, co-existing severe cardiovascular or hepatic disease, and specific concurrent medication use like MAOIs. Individuals without these absolute contraindications may be eligible, though specific chronic conditions require conditional, cautious use as defined by the official labeling.

What should I know about interactions with other medicines?

The official regulatory profile for Panadol Cold (Acetaminophen and Pseudoephedrine) establishes specific restrictions and documented interactions with other medicines and substances. The information below is strictly based on authoritative government drug labels.

Absolute Contraindications

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the official risk of hypertensive crisis; the restriction mandates a separation period of at least fourteen days after stopping the MAOI. Use with any other medicine containing Acetaminophen is also prohibited to avoid exceeding the maximum daily dose and prevent the documented risk of severe liver damage.

Interactions Affecting Blood Pressure and Drug Exposure

  • Pharmacodynamic Interactions: Co-administration with Sympathomimetic Agents (including other decongestants) or Tricyclic Antidepressants may cause an officially described additive pressor effect, leading to increases in blood pressure. Pseudoephedrine may also reduce the effect of Antihypertensive Drugs.
  • Anticoagulants: Prolonged, regular use of Acetaminophen may enhance the anticoagulant effect of Warfarin and other Coumarins. This interaction is clinically significant and may necessitate a documented reduction in the anticoagulant dosage.
  • Absorption and Timing: Substances that decrease absorption, such as Cholestyramine Resin, must be administered at least one hour after Acetaminophen to mitigate reduced drug exposure, as stated in the label.

Alcohol Caution

Official labeling identifies an increased risk of Acetaminophen-induced hepatotoxicity for patients who are chronic, heavy consumers of alcohol (three or more drinks daily), placing this group at a formally documented elevated risk of liver injury.

Mechanism of Action

The combination product Panadol Cold operates via two distinct, complementary pharmacodynamic mechanisms, each functioning through separate biological systems to influence systemic and local physiological pathways.

Central Modulation of Temperature and Pain Signaling

The Acetaminophen component functions by primarily inhibiting Cyclooxygenase ( COX) enzymes within the Central Nervous System ( CNS), specifically interfering with the synthesis of Prostaglandin E2 ( PGE2). This reduction in PGE2 signaling in the hypothalamus supports the return of the elevated temperature set-point and results in an elevation of the central pain threshold via the modulation of nociceptive pathways.

Local Sympathetic Control of Nasal Swelling

The Pseudoephedrine component engages the autonomic sympathetic nervous system by acting as a direct and indirect agonist of alpha1-Adrenergic Receptors (alpha1-AR) located on the small blood vessels in the nasal and sinus lining. This alpha1-AR activation triggers vasoconstriction, or the narrowing of these arterioles, which reduces capillary blood volume and hydrostatic pressure, thus limiting fluid accumulation and tissue volume.

Complementary Mechanism Partitioning

The drug's profile relies on a strategy of mechanism partitioning, where the central CNS pathway is modulated to influence systemic functions (thermal regulation and nociception), while an independent peripheral vascular mechanism is engaged to restrict local tissue fluid volume.

Dosage and Administration Information

The administration of Panadol Cold, a fixed-dose combination product containing Paracetamol and Pseudoephedrine, is designated solely for oral use and is supplied as a tablet or caplet. The standard dosing regimen for adults and the elderly is established as two tablets per dose, while adolescents aged 12 to 15 years are directed to take one tablet per dose.

The dosing schedule follows an intermittent pattern, allowing the dose to be repeated every four to six hours as needed for acute symptom management. However, the dose must not be repeated more frequently than the minimum four-hour interval. A critical administration constraint is the maximum daily dose: users must not exceed eight tablets in a 24-hour period, which limits the total Paracetamol intake to 4,000 mg.

The caplet or tablet must be swallowed whole with a fluid, and no preparation like crushing or dissolving is required. The use of this combination is limited to short-term applications, generally not exceeding five consecutive days. Furthermore, administration-related rules prohibit taking the product concurrently with any other medicine containing Paracetamol or other decongestants to adhere to the maximum daily limits. For pediatric patients, the medicine is not recommended for those under 12 years of age. Patients with hepatic impairment require a modified regimen, often involving a reduced dose or prolonged interval between doses.

Recent Clinical Evidence

Panadol Cold: Recent Clinical Evidence

Evidence for Multi-Symptom Cold and URTI Relief

The research base for this combination of an analgesic (Acetaminophen) and a decongestant (Pseudoephedrine) was studied in research exploring symptoms associated with the common cold. Evidence comes primarily from short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies structured the evaluation around patient-reported outcomes, examining perceived discomfort (like headache and body aches) and outcomes describing episodic changes in overall illness severity. Objective measures, such as nasal airflow, were also included. Research indicates that patterns across the evidence base showed variability due to differences in trial design.


Comparative Research and Study Duration

Studies explored how the combination product performed when compared against a non-active treatment (placebo) to evaluate measured differences and compared it against single active ingredients (monotherapies). This research was relevant in trials assessing short-term or episodic symptom patterns. Follow-up durations are typically short, consisting of single-dose observation periods (4 to 6 hours) or multi-dose treatment periods (3 to 6 days). Because these follow-up durations were limited, the evidence provides context but not individual predictions for how symptom patterns might evolve beyond the initial acute episode.


Evidence Gaps in Specific Populations and Research Uncertainty

The majority of the research was studied for use in adults and adolescents (older children). Scientific reports indicate that data for certain groups remain insufficient, particularly for younger children (under age 12). Research exploring short-term symptom changes in this very young population is limited, and data availability is limited for symptom patterns in this age range. Overall, methodological heterogeneity remains a key limitation, meaning results are variable across studies, and long-term effects are not fully established. The available evidence describes group patterns, not personal outcomes.

Key Studies & References

  1. Pseudoephedrine (NIH StatPearls)
  2. Acetaminophen and Pseudoephedrine Hydrochloride Tablet, Film Coated (NIH DailyMed Label)

Frequently Asked Questions (FAQ)

Common questions about Panadol Cold (FAQ)

Q: What is the main difference between Panadol Cold and regular Panadol?

The difference relates to the active ingredients. The regular Panadol product typically contains only the active ingredient Paracetamol ( Acetaminophen). Panadol Cold, in contrast, is described in official product information as a fixed-dose combination product, which includes Paracetamol along with a second ingredient, such as Pseudoephedrine, to address nasal and sinus congestion.


Q: Can Panadol Cold help with fever, besides the other symptoms?

Regulatory documents describe the Acetaminophen component as an antipyretic agent, which is intended to address fever. The combination product is indicated for the simultaneous relief of multi-symptoms, which often includes elevated body temperature.


Q: What kind of side effects are generally described in the official documents for this medication?

The official safety profile describes commonly reported adverse reactions affecting the Nervous System and Psychiatric Disorders, such as insomnia ( difficulty sleeping), nervousness, and headache. Less commonly reported effects include those affecting the Gastrointestinal ( stomach/intestines), Cardiac, and Vascular systems.


Q: What official information is available about Panadol Cold and alcohol consumption?

Official labeling identifies an increased risk of liver damage ( hepatotoxicity) associated with Acetaminophen for patients who are chronic, heavy consumers of alcohol. Products often carry a general caution regarding alcohol use.


Q: How long after starting Panadol Cold should a person generally expect to notice an effect?

Research studies exploring symptom relief have included observations of changes in nasal airflow as early as 30 seconds to 60 minutes after administration. These studies, which use objective measures, were structured around short-term observation periods for immediate symptom change.


Q: What is the typical duration of effect for a dose of Panadol Cold?

Regulatory guidelines establish the maximum interval between doses as four to six hours. This interval is set by the official administration rules for managing acute symptoms.


Q: Are there specific food types mentioned in official documents that should be avoided with Panadol Cold?

Official documentation mentions timing constraints with specific binding agents, such as Cholestyramine Resin, which must be administered separately from Acetaminophen to mitigate reduced drug absorption. However, common food types are not explicitly listed as restricted in the official labeling.


Q: What is the official information regarding the maximum recommended duration of use for Panadol Cold?

Official guidelines describe the use of this medicine as limited to short-term applications. Regulatory documents generally specify that the medicine should not be used for more than five consecutive days.


Q: What are the intended purposes of the multiple ingredients in Panadol Cold?

The combination product is designed to provide simultaneous multi-symptom relief. Regulatory documents confirm Acetaminophen acts to reduce pain and fever, while Pseudoephedrine is intended to reduce nasal and sinus congestion.


Q: Is Panadol Cold available in different formulations or strengths?

Yes, official regulatory documents and marketed product information confirm that the drug may be supplied in different forms. This may include oral tablets, caplets, effervescent tablets, or powders for oral solution, often with variations in specific component strengths.


Q: Can taking Panadol Cold cause problems with sleep?

The Pseudoephedrine component is a sympathomimetic agent, which can stimulate the body. This component is associated with adverse reactions like insomnia ( difficulty sleeping) and nervousness.


Q: Is there an official classification for Panadol Cold as a non-drowsy or nighttime formula?

Regulatory authorities classify and permit specific formulations of the product to be labeled. This means certain products are officially classified as Non-Drowsy when they do not contain ingredients typically associated with causing sedation.


Q: Is there information about Panadol Cold causing stomach upset?

Regulatory information classifies adverse reactions that affect the Gastrointestinal system. Commonly reported effects in the official safety profile include nausea, vomiting, abdominal pain, and diarrhea.


Q: What research has been done on the ingredient combination in Panadol Cold?

The research base is described as consisting primarily of short-term Randomized Controlled Trials ( RCTs) and Systematic Reviews. These studies examine patient-reported outcomes for multi-symptom cold and flu relief.


Q: What should patients with kidney issues know about Panadol Cold, based on official sources?

Official labeling advises caution for patients with renal impairment ( kidney issues), noting that a modified dosing regimen may be necessary in cases of severe renal impairment. This information is defined in official warnings and precautions.


Q: Does the package insert describe the role of each active ingredient?

Yes, official patient information leaflets ( package inserts) typically contain a dedicated section that describes the role of each component. This clarifies that one ingredient is a painkiller and fever reducer, and the other is a decongestant.


Q: Why is it important to check the active ingredients of other medicines taken with Panadol Cold?

Official documents emphasize checking active ingredients to avoid exceeding the maximum recommended daily dose of Acetaminophen, thereby preventing the risk of severe liver damage. This also helps prevent the risk of additive pressor effects ( increased blood pressure) with other decongestants.


Q: What is the official guidance on managing cold symptoms that persist despite using Panadol Cold?

Official guidance emphasizes that the medicine is for short-term use only. If symptoms persist or worsen after the recommended duration of use, patients should seek advice from a healthcare professional.


Q: What does the research say about combining the active ingredients found in Panadol Cold?

Research studies were specifically structured to evaluate the combination product against a non-active treatment ( placebo) and against the single active ingredients alone. The evidence base describes that these studies explored measured differences in symptom relief across these different comparisons.


Q: Why do people sometimes ask if Panadol Cold is the same as Tylenol Cold?

The comparison is often due to the core component. Panadol contains Paracetamol, and Tylenol contains Acetaminophen. Regulatory bodies confirm that Paracetamol and Acetaminophen are the same chemical substance, which is the basis for the similarity and the frequent comparison between the brands.


Q: What official information is available about taking Panadol Cold with caffeine-containing beverages?

Regulatory guidance notes that the Sympathomimetic Agent component ( Pseudoephedrine) can interact with Caffeine. Official information highlights the potential for additive effects on parameters like heart rate or blood pressure.


Q: Is there any official information about Panadol Cold affecting driving or operating machinery?

Official labeling states that adverse reactions such as dizziness or nervousness may occur. Users are cautioned to consider how the medication affects them before driving or operating machinery.

How should Panadol Cold be stored and disposed of?

Storage and Disposal Requirements

Official regulatory guidelines define strict conditions for the storage and disposal of Panadol Cold to maintain its stability and prevent accidental ingestion.

Item Official Regulatory Statement
Storage Temperature Store the product at or below 25 C (77 F), or at controlled room temperature (20 C to 25 C). Avoid excessive heat above 40 C [FDA, HPRA].
Environmental Protection Keep the medicine in a cool, dry place, protected from moisture. Do not store the product in the bathroom, near a sink, or in a car [NPS MedicineWise].
Child Protection The medicine must be kept out of the sight and reach of children at all times, often recommending a locked cupboard [NPS MedicineWise, HPRA].
Disposal Instructions Unused or expired medication should be returned to a pharmacist for proper disposal or managed through a community drug take-back program. Do not flush the medicine down the toilet [FDA, NPS MedicineWise].

These mandated conditions ensure the product remains viable until its expiry date and is safely removed from household circulation once no longer needed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panadol Cold found in:

A-Z Index: